Clinical Roundup Vulnerable patients have a decreased mortality risk when treated at CoC-accredited hospitals, ACS study says September 27, 2024Vol.50 No.36
Clinical Roundup UCLA investigators develop collection of sarcoma patient-derived organoids for personalized cancer treatments September 27, 2024Vol.50 No.36
Clinical Roundup Imfinzi + chemo shows improved EFS and OS in muscle-invasive bladder cancer September 20, 2024Vol.50 No.35
Clinical Roundup Follow-up data for Imfinzi + Imjudo shows OS benefit in unresectable HCC September 20, 2024Vol.50 No.35
Clinical Roundup Adjuvant Keytruda prolongs DFS in high-risk bladder cancer September 20, 2024Vol.50 No.35
Clinical Roundup Adjuvant treatment with cancer vaccine + Keytruda shows continued improvement in RFS and DMFS in resected high-risk advanced melanoma September 20, 2024Vol.50 No.35
Clinical Roundup Ten-year follow-up data shows Opdivo + Yervoy improves OS in advanced melanoma September 20, 2024Vol.50 No.35
Clinical Roundup Data from phase I/II study shows Rina-S improves ORR for treatment of ovarian cancer September 20, 2024Vol.50 No.35
Clinical Roundup Accelerated partial-breast irradiation is not statistically equivalent to whole-breast irradiation in local tumor control, NRG oncology trial shows September 20, 2024Vol.50 No.35
